An examination of Wuhan City healthcare personnel afflicted with SARS-CoV-2 Omicron variants between December 15, 2022, and January 5, 2023, during the rapid Omicron outbreak in China

Authors

  • Yingyu He Hubei Key Laboratory of Central Nervous System Tumor and Intervention, General Hospital of Central Theater Command of the PLA, Wuhan, Hubei 430070, China
  • Yuan Huang Department of Gynaecology and Obstetrics, General Hospital of Central Theater Command of the PLA, Wuhan, Hubei 430070, China
  • Fang Zhang Department of Anesthesiology, General Hospital of Central Theater Command of the PLA, Wuhan, Hubei 430070, China
  • Shangen Zheng Hubei Key Laboratory of Central Nervous System Tumor and Intervention, General Hospital of Central Theater Command of the PLA, Wuhan, Hubei 430070, China
  • Wanbing Liu Hubei Key Laboratory of Central Nervous System Tumor and Intervention, General Hospital of Central Theater Command of the PLA, Wuhan, Hubei 430070, China
  • Lei Liu Hubei Key Laboratory of Central Nervous System Tumor and Intervention, General Hospital of Central Theater Command of the PLA, Wuhan, Hubei 430070, China https://orcid.org/0000-0001-6764-3260

DOI:

https://doi.org/10.3855/jidc.18050

Keywords:

Healthcare personnel, omicron variants, booster immunization, primary immunization

Downloads

Published

2023-11-30

How to Cite

1.
He Y, Huang Y, Zhang F, Zheng S, Liu W, Liu L (2023) An examination of Wuhan City healthcare personnel afflicted with SARS-CoV-2 Omicron variants between December 15, 2022, and January 5, 2023, during the rapid Omicron outbreak in China. J Infect Dev Ctries 17:1518–1521. doi: 10.3855/jidc.18050

Issue

Vol. 17 No. 11: November 2023

Section

Coronavirus Pandemic

License

Copyright (c) 2023 Yingyu He, Yuan Huang, Fang Zhang, Shangen Zheng, Wanbing Liu, Lei Liu

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC